Material Event (Form 8-K)

Item 8.01 Other Events.

As previously disclosed, in August 2025, Ocugen, Inc. ("Ocugen") closed a registered direct offering, pursuant to a securities purchase agreement with an institutional investor (the "Investor"), for the purchase and sale of 20,000,000 shares of common stock, $0.01 par value per share ("Common Stock"), and warrants to purchase up to an aggregate of 20,000,000 shares of Common Stock.

On March 12, 2026, the Investor purchased 10,000,000 shares of Common Stock upon the partial exercise of its warrants for the gross proceeds of $15.0 million to Ocugen. Ocugen anticipates that proceeds from such partial exercise of the warrants will extend its cash runway into the first quarter of 2027.